GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gujarat Terce Laboratories Ltd (BOM:524314) » Definitions » Cash Ratio

Gujarat Terce Laboratories (BOM:524314) Cash Ratio : 0.00 (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Gujarat Terce Laboratories Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Gujarat Terce Laboratories's Cash Ratio for the quarter that ended in Dec. 2023 was 0.00.

Gujarat Terce Laboratories has a Cash Ratio of 0.00. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Gujarat Terce Laboratories's Cash Ratio or its related term are showing as below:

BOM:524314' s Cash Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.1   Max: 0.24
Current: 0.01

During the past 13 years, Gujarat Terce Laboratories's highest Cash Ratio was 0.24. The lowest was 0.01. And the median was 0.10.

BOM:524314's Cash Ratio is ranked worse than
96.84% of 980 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs BOM:524314: 0.01

Gujarat Terce Laboratories Cash Ratio Historical Data

The historical data trend for Gujarat Terce Laboratories's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gujarat Terce Laboratories Cash Ratio Chart

Gujarat Terce Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 - 0.11 0.11 0.12

Gujarat Terce Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.12 - 0.01 -

Competitive Comparison of Gujarat Terce Laboratories's Cash Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Gujarat Terce Laboratories's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gujarat Terce Laboratories's Cash Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gujarat Terce Laboratories's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Gujarat Terce Laboratories's Cash Ratio falls into.



Gujarat Terce Laboratories Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Gujarat Terce Laboratories's Cash Ratio for the fiscal year that ended in Mar. 2023 is calculated as:

Cash Ratio (A: Mar. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=20.299/166.08
=0.12

Gujarat Terce Laboratories's Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gujarat Terce Laboratories  (BOM:524314) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Gujarat Terce Laboratories Cash Ratio Related Terms

Thank you for viewing the detailed overview of Gujarat Terce Laboratories's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Gujarat Terce Laboratories (BOM:524314) Business Description

Traded in Other Exchanges
N/A
Address
Near Shivalik High-Street,, D/801 & 802,The First,, Behind Keshavbaug Party Plot,, Vastrapur,, Ahmedabad, GJ, IND, 380015
Gujarat Terce Laboratories Ltd is an India company having business in the medical and pharmaceutical preparations. It is engaged in the manufacturing of tablets, capsules, and syrup and injection. It offers branded as well as generic formulations covering different therapeutic areas such as antibiotics, respiratory, nutraceuticals, gastrointestinal, anti-fungal, and many more. Some of the main brands are Acolate, Tynol, DFS, Resplash , Aziter and others.

Gujarat Terce Laboratories (BOM:524314) Headlines

No Headlines